Authors:
Stark, B
Jeison, M
Gobuzov, R
Krug, H
Glaser-Gabay, L
Luria, D
El-Hasid, R
Ben Harush, M
Avrahami, G
Fisher, S
Stein, J
Zaizov, R
Yaniv, I
Citation: B. Stark et al., Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploidline: detection by fluorescence in situ hybridization, CANC GENET, 128(2), 2001, pp. 108-113
Authors:
Kauli, R
Zaizov, R
Lazar, L
Pertzelan, A
Laron, Z
Galatzer, A
Phillip, M
Yaniv, Y
Cohen, IJ
Citation: R. Kauli et al., Delayed growth and puberty in patients with Gaucher disease type 1: Natural history and effect of splenectomy and/or enzyme replacement therapy, ISR MED ASS, 2(2), 2000, pp. 158-163
Authors:
Blau, O
Avigad, S
Stark, B
Benyaminy, H
Luria, D
Kodman, Y
Cohen, IJ
Goshen, Y
Yaniv, I
Zaizov, R
Citation: O. Blau et al., p53 mutation in intron 6 as a diagnostic marker for high risk childhood T-lineage acute lymphoblastic leukemia, INT J PED H, 6(5), 2000, pp. 361-367
Authors:
Eshet, R
Silbergeld, A
Zaizov, R
Stark, B
Freud, F
Laron, Z
Shamai, Y
Citation: R. Eshet et al., Decreased insulin-like growth factor-I receptor sites on circulating mononuclear cells from children with acute leukemia, PED HEM ONC, 17(3), 2000, pp. 253-260
Authors:
Shuper, A
Stark, B
Yaniv, Y
Zaizov, R
Carel, C
Sadeh, M
Steinmetz, A
Citation: A. Shuper et al., Cerebellar involvement in Langerhans' cell histiocytosis: A progressive neuropsychiatric disease, J CHILD NEU, 15(12), 2000, pp. 824-826
Authors:
Stark, B
Jeison, M
Gobuzov, R
Finkelshtein, S
Ash, S
Avrahami, G
Cohen, IJ
Stein, J
Yaniv, I
Zaizov, R
Bar-Am, I
Citation: B. Stark et al., Apparently unrelated clones shown by spectral karyotyping to represent clonal evolution of cryptic t(10;11)(p13;q23) in a patient with acute monoblastic leukemia, CANC GENET, 120(2), 2000, pp. 105-110
Authors:
Stark, B
Sharon, R
Rechavi, G
Attias, D
Ballin, A
Cividalli, G
Burstein, Y
Sthoeger, D
Abramov, A
Zaizov, R
Citation: B. Stark et al., Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with Non-B-Cell acute lymphoblastic leukemia - The Israel National Study Report, CANCER, 88(1), 2000, pp. 205-216
Authors:
Tomer, G
Cohen, IJ
Kidron, D
Katz, K
Yosipovitch, Z
Meller, I
Zaizov, R
Citation: G. Tomer et al., Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center, INT J ONCOL, 15(1), 1999, pp. 179-185
Authors:
Tamary, H
Shalev, H
Pinsk, V
Zoldan, M
Zaizov, R
Citation: H. Tamary et al., No response to recombinant human erythropoietin therapy in patients with congenital dyserythropoietic anemia type I, PED HEM ONC, 16(2), 1999, pp. 165-168
Authors:
Avigad, S
Kuperstein, G
Zilberstein, J
Liberzon, E
Stark, B
Gelernter, I
Kodman, Y
Luria, D
Ash, S
Stein, J
Goshen, Y
Yaniv, I
Cohen, IJ
Zaizov, R
Citation: S. Avigad et al., TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia, LEUKEMIA, 13(3), 1999, pp. 481-483
Authors:
Barel, D
Cohen, IJ
Mor, C
Stern, S
Shapiro, R
Shomrat, R
Galanti, Y
Legum, C
Zaizov, R
Avigad, S
Citation: D. Barel et al., Mutations of the adenomatous polyposis coli and p53 genes in a child with Turcot's syndrome, CANCER LETT, 132(1-2), 1998, pp. 119-125